AMCON Distributing Company reported Q2 2024 (fiscal quarter ended March 31, 2024) revenue of $601.9 million, flat-to-up modestly versus the prior year but down sequentially. Gross profit of $40.0 million yielded a gross margin of approximately 6.65%, reflecting ongoing margin pressure in a price-competitive wholesale/retail distribution environment. Operating income stood at $3.34 million (operating margin ~0.56%), and net income was $0.54 million, translating to basic EPS of $0.90 and diluted EPS of $0.89. While cash flow generation remained favorable, annualization of the effect of debt repayments and modest profitability suggests a cautious near-term stance.
Key drivers observed in QQ2 2024 include a low-but-stable gross margin, contribution from the Wholesale Distribution and Retail Health Food segments, and substantial cash flow from operations ($48.76 million) driven by working capital dynamics. Free cash flow was strong at $41.62 million, aided by a robust operating cash flow and disciplined capital expenditure ($7.14 million). The balance sheet shows a meaningful debt load, with long-term debt of $132.35 million and total debt of $142.86 million, and a debt-to-capitalization of about 57%. The company generated positive operating cash flow but faced a high interest burden and a compressed earnings base, underscoring leverage risk in a volatile retail environment. Management commentary is not included in the transcript data provided; accordingly, this section reflects the 10-Q detail and implied narratives around cost controls, product mix, and balance sheet management.
Overall, the QQ2 2024 results underscore a fragile earnings base in a competitive distribution market, with cash flow strength masking a lean profitability profile. Investors should monitor leverage de-leveraging progress, margin stabilization efforts, and any strategic initiatives to enhance higher-margin revenue streams (e.g., health food/private-label programs) while sustaining inventory/receivables discipline.